HRI awarded NHMRC Development Grant

Awards and Achievements
Dr Steven Wise, Leader of the Applied Materials Group at HRI, has been awarded a prestigious National Health and Medical Research Council (NHMRC) Development Grant for his work inventing a sealant technology for valves used in heart surgery.

Aortic stenosis is the most common heart valve disease, affecting more than one in eight people aged over 75. The standard treatment for this disease is aortic valve replacement, which involves open heart surgery, but almost half of patients requiring treatment are deemed too high risk for this procedure.

The next best treatment option for these patients is transcatheter aortic valve implantation (TAVI), a less invasive approach through keyhole surgery. However, this option is also flawed due to the high potential of the replacement valve to develop a leak.

“Even a moderate leak seriously increases a patient's risk of dying in the three years after the procedure, and attempts to solve this leak problem come with serious risk of stroke and heart damage,” explains Dr Wise. “As a result, many of the highest risk patients are left with no safe treatment option.”

“The innovative hydrogel seal we have developed is able to stop the leak, giving high-risk patients a far safer treatment option to extend their life.”

The Development Grant, awarded to Dr Wise (Chief Investigator B), Associate Professor Martin Ng (Chief Investigator A, Royal Prince Alfred Hospital), and Dr Raj Makkar (Chief Investigator C, Cedars-Sinai Medical Center) in partnership with Sydney-based start-up Endoluminal Sciences, will support work to commercially develop their sealant technology, making a safer and more effective heart valve treatment available to the thousands who need it every year.

The hydrogel sealant technology stops leaks in valves used in heart surgery. Image provided by Dr Wise.

The NHMRC Development Grants scheme supports the commercial development of a research outcome that, if applied, would result in improved health care, disease prevention or provide health cost savings. Only 20 NHMRC Development Grants have been awarded across Australia this year, and only three in NSW.


Related news

Meet the team: Richard Tan

“A career in research really gives you a sense of purpose and drive. While it can be a long and difficult path, every day you can feel satisfied that the work you do is for the greater good. And that in itself is one of the most rewarding experiences,” says Richard Tan, PhD candidate with the Applied Materials Group at HRI.

Read more

Heart patch helps stem cells work magic

The Heart Research Institute is behind the invention of an innovative bio-material patch that can be loaded with a patient’s stem cells to help breathe life into dead tissue following a stroke or heart attack, dramatically improving a patient’s chance of full recovery.

Read more

Smart new nanoparticle makes good drugs brilliant

Scientists at Heart Research Institute have engineered multifunctional nanoparticles that can effectively work as ‘nanocarriers’, hauling a wide range of molecules including drugs or genetic material, to exactly where it needs to go in the body. These super-charged nanoparticles with truck-like power and GPS-style precision are poised to change the way medication is delivered to sick Australians.

Read more